To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Therapeutic radiation is essential for cancer treatment, particularly in brain tumors. Modern advancements such as linear accelerators, MRI/PET/CT imaging, and intensity-modulated radiotherapy (IMRT) have improved precision and reduced normal tissue toxicity. Radiation modifiers, agents that enhance tumor cell killing or protect normal tissues, have been developed to optimize radiation therapy. Historical approaches include oxygen therapy and nitroimidazole compounds, while contemporary strategies involve radiosensitizing chemotherapy, molecular agents, and nanotechnology. Future developments focus on targeted molecular agents, tumor-treating fields (TTF), ketogenic diets, and immunotherapy. Despite progress, managing brain tumors remains challenging due to normal tissue toxicity and the need for further research to enhance therapeutic outcomes.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.